Lazard Asset Management LLC Ab Cellera Biologics Inc. Transaction History

Lazard Asset Management LLC

$58.2 Billion
Q1 2025

A detailed history of Lazard Asset Management LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 833,162 shares of ABCL stock, worth $1.92 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

833,162

Previous 928,594 10.28%

Holding current value

$1.92 Million

Previous $2.72 Million 31.73%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$2.2 - $3.53 $209,950 - $336,874	-95,432 Reduced 10.28%	833,162 $1.86 Million
Q4 2024 Feb 14, 2025	SELL	$2.48 - $3.15 $416,592 - $529,140	-167,981 Reduced 15.32%	928,594 $2.72 Million
Q3 2024 Nov 14, 2024	BUY	$2.39 - $3.49 $10,530 - $15,376	4,406 Added 0.4%	1,096,575 $2.84 Million
Q2 2024 Aug 14, 2024	SELL	$2.73 - $4.73 $2.53 Million - $4.39 Million	-927,843 Reduced 45.93%	1,092,169 $3.23 Million
Q1 2024 May 14, 2024	SELL	$4.29 - $5.97 $5.97 Million - $8.31 Million	-1,391,993 Reduced 40.8%	2,020,012 $9.15 Million
Q4 2023 Feb 14, 2024	BUY	$3.91 - $5.93 $1.04 Million - $1.57 Million	265,172 Added 8.43%	3,412,005 $19.5 Million
Q3 2023 Nov 14, 2023	SELL	$4.6 - $7.95 $590,952 - $1.02 Million	-128,468 Reduced 3.92%	3,146,833 $14.5 Million
Q2 2023 Aug 14, 2023	BUY	$5.66 - $7.59 $181,697 - $243,654	32,102 Added 0.99%	3,275,301 $21.2 Million
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $2.46 Million - $3.77 Million	336,987 Added 11.6%	3,243,199 $24.5 Million
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $3.59 Million - $5.5 Million	-378,810 Reduced 11.53%	2,906,212 $29.4 Million
Q3 2022 Nov 14, 2022	SELL	$9.2 - $13.68 $565,570 - $840,978	-61,475 Reduced 1.84%	3,285,022 $32.5 Million
Q2 2022 Aug 09, 2022	BUY	$5.72 - $10.65 $896,095 - $1.67 Million	156,660 Added 4.91%	3,346,497 $35.6 Million
Q1 2022 May 13, 2022	BUY	$7.46 - $14.14 $21.6 Million - $41 Million	2,899,091 Added 997.12%	3,189,837 $31.1 Million
Q4 2021 Feb 09, 2022	BUY	$12.99 - $17.73 $1.95 Million - $2.65 Million	149,738 Added 106.19%	290,746 $4.16 Million
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $2.09 Million - $3.01 Million	141,008 New	141,008 $2.83 Million

Others Institutions Holding ABCL

# of Institutions

150

Shares Held

132M

Call Options Held

156K

Put Options Held

346K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $659M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Ab Cellera Biologics Inc. Transaction History